See more : W.R. Berkley Corporation 5.10% (WRB-PF) Income Statement Analysis – Financial Results
Complete financial analysis of Double Medical Technology Inc. (002901.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Double Medical Technology Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- Sarda Energy & Minerals Limited (SARDAEN.BO) Income Statement Analysis – Financial Results
- AMD Industries Limited (AMDIND.NS) Income Statement Analysis – Financial Results
- InRetail Perú Corp. (INREF) Income Statement Analysis – Financial Results
- PT Satyamitra Kemas Lestari Tbk (SMKL.JK) Income Statement Analysis – Financial Results
- Verra Mobility Corporation (VRRMW) Income Statement Analysis – Financial Results
Double Medical Technology Inc. (002901.SZ)
About Double Medical Technology Inc.
Double Medical Technology Inc. provides services, technologies, and devices in the areas of orthopedics, wound management, neurosurgery, and general surgery in China. It also exports its products to approximately 50 countries and regions, including European Union, Russia, South America, Australia, Southeast Asia, the Middle East, and South Africa. The company was formerly known as Xiamen Da Bo Ying Jing Medical Equipment Company Limited. Double Medical Technology Inc. was founded in 2004 and is based in Xiamen, the People's Republic of China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.53B | 1.43B | 1.99B | 1.59B | 1.26B | 772.47M | 594.01M | 462.66M | 391.83M | 298.89M | 202.65M |
| Cost of Revenue | 527.79M | 333.92M | 311.06M | 224.23M | 180.92M | 151.43M | 100.60M | 83.46M | 74.32M | 59.43M | 41.98M |
| Gross Profit | 1.01B | 1.10B | 1.68B | 1.36B | 1.08B | 621.04M | 493.41M | 379.20M | 317.51M | 239.46M | 160.67M |
| Gross Profit Ratio | 65.57% | 76.72% | 84.40% | 85.87% | 85.61% | 80.40% | 83.06% | 81.96% | 81.03% | 80.12% | 79.28% |
| Research & Development | 285.28M | 256.72M | 167.07M | 128.02M | 100.38M | 64.81M | 53.66M | 39.96M | 35.78M | 23.80M | 0.00 |
| General & Administrative | 31.54M | 38.93M | 23.19M | 16.47M | 14.20M | 12.75M | 9.17M | 14.72M | 10.73M | 6.03M | 29.11M |
| Selling & Marketing | 365.72M | 662.89M | 655.18M | 502.49M | 409.85M | 120.95M | 72.20M | 52.97M | 41.74M | 28.16M | 20.34M |
| SG&A | 665.54M | 701.83M | 678.37M | 518.96M | 424.05M | 133.69M | 81.37M | 67.69M | 52.46M | 34.19M | 49.45M |
| Other Expenses | -43.88M | 25.67M | 19.84M | 6.92M | 100.42K | -84.05K | -595.36K | 18.60M | 9.92M | 7.09M | 5.64M |
| Operating Expenses | 937.65M | 984.21M | 865.28M | 653.90M | 524.53M | 208.14M | 139.97M | 138.92M | 110.06M | 75.41M | 52.84M |
| Cost & Expenses | 1.43B | 1.32B | 1.18B | 878.13M | 705.45M | 359.57M | 240.58M | 222.38M | 184.38M | 134.84M | 94.82M |
| Interest Income | 29.91M | 21.03M | 14.44M | 23.72M | 26.59M | 11.93M | 2.63M | 219.70K | 296.08K | 86.71K | -0.29 |
| Interest Expense | 7.16M | 3.10M | 549.07K | 142.73K | 92.10K | 115.61K | 3.22M | 3.43M | 619.79K | 798.89K | 463.60K |
| Depreciation & Amortization | 111.90M | 137.51M | 82.06M | 51.58M | 41.66M | 30.03M | 25.42M | 25.86M | 17.61M | 12.89M | -1.55M |
| EBITDA | 218.79M | 246.07M | 873.91M | 759.06M | 591.65M | 441.53M | 375.58M | 287.53M | 237.71M | 180.06M | 107.34M |
| EBITDA Ratio | 14.27% | 17.85% | 45.02% | 48.61% | 48.31% | 61.72% | 64.26% | 57.47% | 60.62% | 62.44% | 52.97% |
| Operating Income | 103.24M | 147.45M | 822.01M | 714.74M | 571.00M | 440.79M | 350.93M | 242.98M | 213.92M | 159.68M | 108.89M |
| Operating Income Ratio | 6.73% | 10.28% | 41.22% | 45.04% | 45.41% | 57.06% | 59.08% | 52.52% | 54.59% | 53.42% | 53.73% |
| Total Other Income/Expenses | -3.50M | 126.77K | -19.49M | -5.11M | -2.02M | -84.04K | -595.36K | 18.45M | 9.89M | 6.68M | 5.64M |
| Income Before Tax | 99.74M | 147.46M | 802.51M | 709.63M | 568.98M | 440.70M | 350.33M | 261.52M | 223.81M | 166.37M | 114.53M |
| Income Before Tax Ratio | 6.51% | 10.28% | 40.24% | 44.72% | 45.25% | 57.05% | 58.98% | 56.52% | 57.12% | 55.66% | 56.52% |
| Income Tax Expense | 13.40M | 38.23M | 111.01M | 94.88M | 90.27M | 62.62M | 49.74M | 39.59M | 35.11M | 28.15M | 17.93M |
| Net Income | 58.97M | 92.56M | 673.31M | 605.68M | 465.49M | 371.45M | 295.56M | 219.33M | 188.51M | 139.29M | 96.81M |
| Net Income Ratio | 3.85% | 6.45% | 33.76% | 38.17% | 37.02% | 48.09% | 49.76% | 47.41% | 48.11% | 46.60% | 47.77% |
| EPS | 0.14 | 0.22 | 1.68 | 1.51 | 1.16 | 0.93 | 0.80 | 0.61 | 0.59 | 2.68 | 0.30 |
| EPS Diluted | 0.14 | 0.22 | 1.67 | 1.51 | 1.16 | 0.93 | 0.80 | 0.61 | 0.59 | 2.68 | 0.30 |
| Weighted Avg Shares Out | 421.23M | 414.02M | 400.78M | 400.07M | 400.10M | 399.41M | 369.45M | 359.55M | 319.50M | 319.50M | 319.50M |
| Weighted Avg Shares Out (Dil) | 421.23M | 414.02M | 403.18M | 400.07M | 400.10M | 399.41M | 369.45M | 359.55M | 319.50M | 319.50M | 319.50M |
Source: https://incomestatements.info
Category: Stock Reports